(S)-amphetamine increases expression ISO RGD:10598 6480464 Dextroamphetamine results in increased expression of FOSL2 mRNA CTD PMID:12205029 (S)-amphetamine multiple interactions ISO RGD:10598 6480464 SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of FOSL2 mRNA] CTD PMID:12205029 1,1-dichloroethene increases expression ISO RGD:10598 6480464 vinylidene chloride results in increased expression of FOSL2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:10598 6480464 1, 2-Dimethylhydrazine results in decreased expression of FOSL2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:733116 6480464 Dinitrochlorobenzene results in increased expression of FOSL2 mRNA CTD PMID:17374397 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of FOSL2 mRNA CTD PMID:16079270 17beta-estradiol increases expression ISO RGD:10598 6480464 Estradiol results in increased expression of FOSL2 mRNA CTD PMID:25210133 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FOSL2 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:733116 6480464 Estradiol results in increased expression of FOSL2 mRNA CTD PMID:31614463 , PMID:32387340 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FOSL2 mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:733116 6480464 Dihydrotestosterone results in increased expression of FOSL2 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10598 6480464 Tetrachlorodibenzodioxin affects the expression of FOSL2 mRNA CTD PMID:24058054 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FOSL2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733116 6480464 Tetrachlorodibenzodioxin results in increased expression of FOSL2 mRNA CTD PMID:22903824 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733116 6480464 Tetrachlorodibenzodioxin affects the expression of FOSL2 protein CTD PMID:16985168 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-butoxyethanol increases expression ISO RGD:10598 6480464 n-butoxyethanol results in increased expression of FOSL2 mRNA CTD PMID:19812364 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733116 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FOSL2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:10598 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FOSL2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:10598 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of FOSL2 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO RGD:733116 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of FOSL2 gene CTD PMID:31601247 4-hydroxyphenyl retinamide decreases expression ISO RGD:10598 6480464 Fenretinide results in decreased expression of FOSL2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:733116 6480464 Decitabine results in increased expression of FOSL2 mRNA CTD PMID:17908484 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FOSL2 mRNA CTD PMID:25825206 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of FOSL2 mRNA CTD PMID:12800193 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of FOSL2 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:733116 6480464 Acrylamide results in increased expression of FOSL2 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:733116 6480464 Aflatoxin B1 results in increased expression of FOSL2 mRNA CTD PMID:21641981 , PMID:22100608 aflatoxin B1 decreases methylation ISO RGD:733116 6480464 Aflatoxin B1 results in decreased methylation of FOSL2 gene CTD PMID:27153756 aldehydo-D-glucose increases expression ISO RGD:10598 6480464 Glucose results in increased expression of FOSL2 mRNA CTD PMID:17178593 all-trans-retinoic acid increases expression ISO RGD:733116 6480464 Tretinoin results in increased expression of FOSL2 mRNA CTD PMID:23724009 , PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:10598 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of FOSL2 mRNA, [bisphenol F co-treated with Tretinoin] results in decreased expression of FOSL2 mRNA CTD PMID:30951980 amphetamine decreases expression ISO RGD:733116 6480464 Amphetamine results in decreased expression of FOSL2 protein CTD PMID:15814102 amphetamine multiple interactions ISO RGD:733116 6480464 Amphetamine promotes the reaction [JUND protein binds to FOSL2 protein], Amphetamine results in increased activity of [JUND protein binds to FOSL2 protein] CTD PMID:15814102 antirheumatic drug decreases expression ISO RGD:733116 6480464 Antirheumatic Agents results in decreased expression of FOSL2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:733116 6480464 aristolochic acid I results in decreased expression of FOSL2 mRNA, aristolochic acid I results in decreased expression of FOSL2 protein CTD PMID:33212167 arsenite(3-) affects expression ISO RGD:733116 6480464 arsenite affects the expression of FOSL2 mRNA CTD PMID:22959463 atrazine increases expression ISO RGD:733116 6480464 Atrazine results in increased expression of FOSL2 mRNA CTD PMID:22378314 benzene increases expression ISO RGD:10598 6480464 Benzene results in increased expression of FOSL2 mRNA CTD PMID:12928149 benzo[a]pyrene increases expression ISO RGD:10598 6480464 Benzo(a)pyrene results in increased expression of FOSL2 mRNA CTD PMID:21569818 benzo[a]pyrene affects methylation ISO RGD:733116 6480464 Benzo(a)pyrene affects the methylation of FOSL2 intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:733116 6480464 Benzo(a)pyrene results in increased expression of FOSL2 mRNA CTD PMID:20064835 more ... benzo[a]pyrene affects expression ISO RGD:733116 6480464 Benzo(a)pyrene affects the expression of FOSL2 mRNA CTD PMID:21714911 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733116 6480464 7 more ... CTD PMID:20018196 bis(2-ethylhexyl) phthalate increases expression ISO RGD:733116 6480464 Diethylhexyl Phthalate results in increased expression of FOSL2 mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FOSL2 mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FOSL2 mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:733116 6480464 bisphenol A analog results in increased expression of FOSL2 mRNA CTD PMID:32387340 bisphenol A multiple interactions ISO RGD:10598 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of FOSL2 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:10598 6480464 bisphenol A results in increased expression of FOSL2 mRNA CTD PMID:30951980 bisphenol A affects methylation ISO RGD:10598 6480464 bisphenol A affects the methylation of FOSL2 promoter CTD PMID:27334623 Bisphenol B increases expression ISO RGD:733116 6480464 bisphenol B results in increased expression of FOSL2 mRNA CTD PMID:32387340 bisphenol F multiple interactions ISO RGD:733116 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FOSL2 mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO RGD:10598 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of FOSL2 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:10598 6480464 bisphenol F results in increased expression of FOSL2 mRNA CTD PMID:30951980 butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of FOSL2 mRNA CTD PMID:12800193 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of FOSL2 mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:733116 6480464 Cadmium results in increased expression of FOSL2 mRNA CTD PMID:24376830 cadmium atom multiple interactions ISO RGD:733116 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FOSL2 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO RGD:733116 6480464 Cadmium Chloride results in increased expression of FOSL2 mRNA, Cadmium Chloride results in increased expression of FOSL2 protein CTD PMID:21219922 , PMID:25596134 cadmium dichloride multiple interactions ISO RGD:733116 6480464 [Cadmium Chloride co-treated with deoxynivalenol] results in increased expression of FOSL2 mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FOSL2 mRNA CTD PMID:33309878 , PMID:35301059 calcitriol increases expression ISO RGD:733116 6480464 Calcitriol results in increased expression of FOSL2 mRNA CTD PMID:16002434 , PMID:26485663 carbon nanotube increases expression ISO RGD:10598 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chlorpromazine affects expression ISO RGD:10598 6480464 Chlorpromazine affects the expression of FOSL2 mRNA CTD PMID:20843724 cidofovir anhydrous decreases expression ISO RGD:733116 6480464 Cidofovir results in decreased expression of FOSL2 mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:733116 6480464 Cisplatin results in increased expression of FOSL2 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:733116 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of FOSL2 mRNA], jinfukang promotes the reaction [Cisplatin results in decreased expression of FOSL2 mRNA] CTD PMID:27392435 cisplatin decreases expression ISO RGD:733116 6480464 Cisplatin results in decreased expression of FOSL2 mRNA CTD PMID:25596134 clodronic acid decreases expression ISO RGD:733116 6480464 Clodronic Acid results in decreased expression of FOSL2 mRNA CTD PMID:25596134 clozapine increases expression EXP 6480464 Clozapine results in increased expression of FOSL2 mRNA CTD PMID:12093589 , PMID:12243769 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of FOSL2 mRNA CTD PMID:24386269 cocaine multiple interactions ISO RGD:733116 6480464 Cocaine promotes the reaction [JUN protein binds to FOSL2 protein] CTD PMID:15814102 cocaine multiple interactions ISO RGD:10598 6480464 [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSL2 protein more ... CTD PMID:15056714 cocaine decreases expression ISO RGD:733116 6480464 Cocaine results in decreased expression of FOSL2 protein CTD PMID:15814102 copper atom decreases expression EXP 6480464 Copper results in decreased expression of FOSL2 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of FOSL2 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:733116 6480464 Copper Sulfate results in increased expression of FOSL2 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:733116 6480464 coumarin results in increased phosphorylation of FOSL2 protein CTD PMID:35688186 crocidolite asbestos increases expression ISO RGD:733116 6480464 Asbestos more ... CTD PMID:16966607 , PMID:18687144 curcumin decreases expression ISO RGD:733116 6480464 Curcumin results in decreased expression of FOSL2 mRNA CTD PMID:17999991 curcumin multiple interactions ISO RGD:733116 6480464 Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOSL2 protein] CTD PMID:17148446 cyclosporin A increases expression ISO RGD:733116 6480464 Cyclosporine results in increased expression of FOSL2 mRNA CTD PMID:25562108 D-glucose increases expression ISO RGD:10598 6480464 Glucose results in increased expression of FOSL2 mRNA CTD PMID:17178593 deoxynivalenol affects activity ISO RGD:10598 6480464 deoxynivalenol affects the activity of FOSL2 protein CTD PMID:10662601 deoxynivalenol multiple interactions ISO RGD:733116 6480464 [Cadmium Chloride co-treated with deoxynivalenol] results in increased expression of FOSL2 mRNA CTD PMID:33309878 deoxynivalenol increases expression ISO RGD:733116 6480464 deoxynivalenol results in increased expression of FOSL2 mRNA, deoxynivalenol results in increased expression of FOSL2 protein CTD PMID:33309878 , PMID:33890134 deoxynivalenol multiple interactions ISO RGD:10598 6480464 Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of FOSL2 mRNA] CTD PMID:15681167 deoxynivalenol increases expression ISO RGD:10598 6480464 deoxynivalenol results in increased expression of FOSL2 mRNA CTD PMID:15371230 , PMID:15681167 dexamethasone increases expression ISO RGD:10598 6480464 Dexamethasone results in increased expression of FOSL2 mRNA CTD PMID:17998272 dexamethasone multiple interactions ISO RGD:733116 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FOSL2 mRNA CTD PMID:28628672 dibutyl phthalate increases expression ISO RGD:10598 6480464 Dibutyl Phthalate results in increased expression of FOSL2 mRNA CTD PMID:17361019 , PMID:21266533 diclofenac increases expression ISO RGD:10598 6480464 Diclofenac results in increased expression of FOSL2 mRNA CTD PMID:26934552 dieldrin increases expression ISO RGD:733116 6480464 Dieldrin results in increased expression of FOSL2 mRNA CTD PMID:31068361 dimethylarsinous acid increases expression ISO RGD:733116 6480464 dimethylarsinous acid results in increased expression of FOSL2 mRNA CTD PMID:23487506 dioxygen increases expression ISO RGD:733116 6480464 Oxygen deficiency results in increased expression of FOSL2 mRNA CTD PMID:25596134 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FOSL2 mRNA CTD PMID:33729688 dioxygen multiple interactions ISO RGD:10598 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOSL2 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:733116 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733116 6480464 Doxorubicin results in decreased expression of FOSL2 mRNA CTD PMID:29803840 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of FOSL2 mRNA CTD PMID:17920746 ethanol affects expression ISO RGD:10598 6480464 Ethanol affects the expression of FOSL2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:733116 6480464 Ethyl Methanesulfonate results in increased expression of FOSL2 mRNA CTD PMID:23649840 eugenol increases expression ISO RGD:733116 6480464 Eugenol results in increased expression of FOSL2 mRNA CTD PMID:17374397 fluoranthene multiple interactions ISO RGD:10598 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOSL2 mRNA CTD PMID:28329830 formaldehyde increases expression ISO RGD:733116 6480464 Formaldehyde results in increased expression of FOSL2 mRNA CTD PMID:23649840 gemcitabine decreases expression ISO RGD:733116 6480464 Gemcitabine results in decreased expression of FOSL2 mRNA CTD PMID:17039268 geraniol increases expression ISO RGD:733116 6480464 geraniol results in increased expression of FOSL2 mRNA CTD PMID:27683099 glucose increases expression ISO RGD:10598 6480464 Glucose results in increased expression of FOSL2 mRNA CTD PMID:17178593 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of FOSL2 mRNA CTD PMID:24915197 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of FOSL2 mRNA CTD PMID:12243769 hexadecanoic acid increases expression ISO RGD:10598 6480464 Palmitic Acid results in increased expression of FOSL2 mRNA CTD PMID:34968464 hexadecanoic acid multiple interactions ISO RGD:10598 6480464 Palmitic Acid inhibits the reaction [sodium arsenite results in increased expression of FOSL2 mRNA], sodium arsenite inhibits the reaction [Palmitic Acid results in increased expression of FOSL2 mRNA] CTD PMID:34968464 hydrogen chloride decreases expression ISO RGD:733116 6480464 Hydrochloric Acid results in decreased expression of FOSL2 mRNA CTD PMID:15046208 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of FOSL2 mRNA CTD PMID:25972201 indometacin multiple interactions ISO RGD:733116 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FOSL2 mRNA CTD PMID:28628672 ionomycin multiple interactions ISO RGD:733116 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOSL2 mRNA, pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOSL2 mRNA] CTD PMID:15477007 isoprenaline multiple interactions ISO RGD:10598 6480464 [N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with U 0126] inhibits the reaction [Isoproterenol results in increased expression of FOSL2 mRNA], U 0126 inhibits the reaction [Isoproterenol results in increased expression of FOSL2 mRNA] CTD PMID:21177286 isoprenaline increases expression ISO RGD:10598 6480464 Isoproterenol results in increased expression of FOSL2 mRNA, Isoproterenol results in increased expression of FOSL2 protein CTD PMID:21177286 ivermectin decreases expression ISO RGD:733116 6480464 Ivermectin results in decreased expression of FOSL2 protein CTD PMID:32959892 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of FOSL2 mRNA CTD PMID:19700661 lead(0) affects expression ISO RGD:733116 6480464 Lead affects the expression of FOSL2 mRNA CTD PMID:28903495 leflunomide increases expression ISO RGD:733116 6480464 leflunomide results in increased expression of FOSL2 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of FOSL2 mRNA] CTD PMID:16415329 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of FOSL2 mRNA CTD PMID:16415329 mechlorethamine increases expression ISO RGD:10598 6480464 Mechlorethamine results in increased expression of FOSL2 protein CTD PMID:31639410 mechlorethamine multiple interactions ISO RGD:733116 6480464 FOSL2 protein affects the reaction [Mechlorethamine results in increased secretion of CXCL8 protein] CTD PMID:31639410 mercury dibromide increases expression ISO RGD:733116 6480464 mercuric bromide results in increased expression of FOSL2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:733116 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOSL2 mRNA CTD PMID:27188386 methyl methanesulfonate increases expression ISO RGD:733116 6480464 Methyl Methanesulfonate results in increased expression of FOSL2 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:733116 6480464 methylmercuric chloride results in increased expression of FOSL2 mRNA CTD PMID:28001369 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:10598 6480464 [N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with U 0126] inhibits the reaction [Isoproterenol results in increased expression of FOSL2 mRNA] CTD PMID:21177286 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of FOSL2 mRNA] CTD PMID:16415329 nickel atom increases expression ISO RGD:733116 6480464 Nickel results in increased expression of FOSL2 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression ISO RGD:733116 6480464 nickel chloride results in increased expression of FOSL2 mRNA CTD PMID:17312168 nickel sulfate decreases expression ISO RGD:733116 6480464 nickel sulfate results in decreased expression of FOSL2 mRNA CTD PMID:16780908 nickel sulfate increases expression ISO RGD:733116 6480464 nickel sulfate results in increased expression of FOSL2 mRNA CTD PMID:16780908 , PMID:17374397 p-chloromercuribenzoic acid increases expression ISO RGD:733116 6480464 p-Chloromercuribenzoic Acid results in increased expression of FOSL2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:733116 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOSL2 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:10598 6480464 Acetaminophen affects the expression of FOSL2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:733116 6480464 Acetaminophen results in decreased expression of FOSL2 mRNA CTD PMID:21420995 paracetamol multiple interactions ISO RGD:10598 6480464 MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of FOSL2 mRNA] CTD PMID:18700144 paraquat increases expression EXP 6480464 Paraquat results in increased expression of FOSL2 mRNA CTD PMID:32680482 phenobarbital decreases expression ISO RGD:10598 6480464 Phenobarbital results in decreased expression of FOSL2 mRNA CTD PMID:19270015 phenylmercury acetate increases expression ISO RGD:733116 6480464 Phenylmercuric Acetate results in increased expression of FOSL2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733116 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOSL2 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases expression ISO RGD:733116 6480464 Tetradecanoylphorbol Acetate results in increased expression of FOSL2 protein CTD PMID:17148446 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733116 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOSL2 mRNA more ... CTD PMID:15477007 more ... pregnenolone 16alpha-carbonitrile increases expression ISO RGD:10598 6480464 Pregnenolone Carbonitrile results in increased expression of FOSL2 mRNA CTD PMID:28903501 prostaglandin F2alpha increases expression EXP 6480464 Dinoprost results in increased expression of FOSL2 mRNA CTD PMID:11517196 pyrrolidine dithiocarbamate multiple interactions ISO RGD:733116 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOSL2 mRNA] CTD PMID:15477007 raloxifene multiple interactions ISO RGD:733116 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of FOSL2 mRNA CTD PMID:19059307 ranitidine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of FOSL2 mRNA] CTD PMID:16415329 rimonabant multiple interactions EXP 6480464 Rimonabant inhibits the reaction [Dronabinol results in increased expression of FOSL2 protein] CTD PMID:9751146 SB 431542 multiple interactions ISO RGD:733116 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:733116 6480464 Silicon Dioxide analog results in increased expression of FOSL2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:10598 6480464 Silicon Dioxide results in increased expression of FOSL2 mRNA CTD PMID:23221170 silver atom affects expression ISO RGD:10598 6480464 Silver affects the expression of FOSL2 mRNA CTD PMID:27131904 silver atom increases expression ISO RGD:733116 6480464 Silver results in increased expression of FOSL2 mRNA CTD PMID:26014281 silver(0) affects expression ISO RGD:10598 6480464 Silver affects the expression of FOSL2 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:733116 6480464 Silver results in increased expression of FOSL2 mRNA CTD PMID:26014281 simvastatin multiple interactions ISO RGD:10598 6480464 Simvastatin affects the reaction [lipopolysaccharide, E coli O55-B5 promotes the reaction [JUN protein binds to JUNB protein binds to FOS protein binds to FOSB protein binds to FOSL2 protein]] CTD PMID:15187114 SL-327 multiple interactions ISO RGD:10598 6480464 SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSL2 protein], SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOSL2 protein] CTD PMID:15056714 sodium arsenite increases expression ISO RGD:10598 6480464 sodium arsenite results in increased expression of FOSL2 mRNA CTD PMID:11353140 , PMID:34968464 sodium arsenite multiple interactions ISO RGD:10598 6480464 Palmitic Acid inhibits the reaction [sodium arsenite results in increased expression of FOSL2 mRNA], sodium arsenite inhibits the reaction [Palmitic Acid results in increased expression of FOSL2 mRNA] CTD PMID:34968464 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of FOSL2 mRNA CTD PMID:22110744 Soman increases expression EXP 6480464 Soman results in increased expression of FOSL2 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:10598 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FOSL2 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:733116 6480464 Sunitinib results in decreased expression of FOSL2 mRNA CTD PMID:31533062 T-2 toxin increases expression ISO RGD:733116 6480464 T-2 Toxin results in increased expression of FOSL2 mRNA CTD PMID:34581912 tamoxifen multiple interactions ISO RGD:733116 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of FOSL2 mRNA CTD PMID:19059307 testosterone increases expression ISO RGD:10598 6480464 Testosterone deficiency results in increased expression of FOSL2 mRNA CTD PMID:33848595 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FOSL2 mRNA CTD PMID:32741896 tetrachloroethene increases expression ISO RGD:10598 6480464 Tetrachloroethylene results in increased expression of FOSL2 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FOSL2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:10598 6480464 Carbon Tetrachloride results in increased expression of FOSL2 mRNA CTD PMID:31919559 torcetrapib increases expression ISO RGD:733116 6480464 torcetrapib results in increased expression of FOSL2 mRNA CTD PMID:23228038 triclosan increases expression ISO RGD:733116 6480464 Triclosan results in increased expression of FOSL2 mRNA CTD PMID:30510588 trovafloxacin increases expression ISO RGD:10598 6480464 trovafloxacin results in increased expression of FOSL2 mRNA CTD PMID:35537566 urethane increases expression ISO RGD:733116 6480464 Urethane results in increased expression of FOSL2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:10598 6480464 Valproic Acid affects the expression of FOSL2 mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:733116 6480464 Valproic Acid results in increased expression of FOSL2 mRNA CTD PMID:28001369 valproic acid decreases expression ISO RGD:733116 6480464 Valproic Acid results in decreased expression of FOSL2 mRNA CTD PMID:28001369 valproic acid increases methylation ISO RGD:733116 6480464 Valproic Acid results in increased methylation of FOSL2 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:10598 6480464 Vancomycin results in decreased expression of FOSL2 mRNA CTD PMID:18930951 vincristine increases expression ISO RGD:733116 6480464 Vincristine results in increased expression of FOSL2 mRNA CTD PMID:23649840 vorinostat multiple interactions ISO RGD:733116 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FOSL2 mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:733116 6480464 vorinostat results in decreased expression of FOSL2 mRNA CTD PMID:26272509 zinc atom multiple interactions ISO RGD:733116 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FOSL2 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FOSL2 mRNA CTD PMID:16979875 , PMID:18593933 zinc atom decreases expression ISO RGD:733116 6480464 Zinc deficiency results in decreased expression of FOSL2 mRNA CTD PMID:18356318 zinc(0) multiple interactions ISO RGD:733116 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FOSL2 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FOSL2 mRNA CTD PMID:16979875 , PMID:18593933 zinc(0) decreases expression ISO RGD:733116 6480464 Zinc deficiency results in decreased expression of FOSL2 mRNA CTD PMID:18356318